Diabetes

Diabetes

• US panel wants changes to Avandia safety measures

  US government health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis ... 

• FDA weighs lifting safety restrictions on Avandia

  A former blockbuster diabetes pill that was subjected to major safety restrictions in 2010 may be less risky than once thought, according to the ... 

• France: trial of drug maker postponed

  The trial of makers of a diabetes and weight loss drug suspected in hundreds of deaths has been delayed by presiding judge to allow further ... 

• 

  France: Drugmaker on trial, suspected in deaths

  The makers of a diabetes and weight loss drug suspected in the deaths of hundreds of people went on trial Tuesday, facing charges they misled the ... 

• US probes new pancreas risks with diabetes drugs

  The U.S. Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of ... 

• Novo Nordisk says FDA rejects insulin drugs

  Novo Nordisk AS says the Food and Drug Administration rejected its applications for approval of once-per-day insulin drugs to treat diabetes.